Cyclerion Therapeutics In...

2.40
-0.27 (-10.11%)
At close: Mar 03, 2025, 3:59 PM
2.05
-14.58%
After-hours: Mar 03, 2025, 04:35 PM EST

Cyclerion Therapeutics Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue n/a 297K 3.32M 2.3M 4.51M n/a n/a n/a
Cost of Revenue n/a 65K 472K n/a n/a 1.53M 1.75M 2.17M
Gross Profit n/a 232K 2.85M 2.3M 4.51M -1.53M -1.75M -2.17M
Operating Income -9.65M -44.37M -55.2M -81.27M -125.04M -115.25M -93.92M -63.55M
Interest Income 358K 294K n/a 588K 2.03M n/a n/a n/a
Pretax Income -12.59M -44.08M -51.65M -77.8M -123.01M -115.25M -93.92M -63.55M
Net Income -21.02M -43.78M -51.66M -72.67M -120.98M -115.25M -93.92M -63.55M
Selling & General & Admin 8.13M 14.5M 20.62M 28.82M 34.4M 27.54M 15.12M 10.48M
Research & Development 1.51M 31.49M 37.64M 56.41M 95.14M 87.72M 78.8M 50.9M
Other Expenses n/a -1.33M -622K n/a n/a n/a n/a n/a
Operating Expenses 9.65M 44.67M 57.63M 85.23M 129.54M 115.25M 93.92M 61.38M
Interest Expense n/a 294K 16K n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 9.65M 44.67M 57.63M 85.23M 129.54M 115.25M 93.92M 63.55M
Income Tax n/a -294K 16K -5.13M -2.03M 1.37M n/a n/a
Shares Outstanding (Basic) 2.34M 2.17M 1.96M 1.52M 1.37M 1.37M 1.37M 1.37M
Shares Outstanding (Diluted) 2.34M 2.17M 1.96M 1.52M 1.37M 1.37M 1.37M 1.37M
EPS (Basic) -8.99 -20.15 -26.4 -47.8 -88.37 -84.42 -68.8 -46.39
EPS (Diluted) -8.99 -20.15 -26.4 -47.8 -88.37 -84.42 -68.8 -46.39
EBITDA -12.59M -18.18M -55.2M -81.27M -122.34M -113.72M -92.18M -61.38M
Depreciation & Amortization -2.95M 65K 472K 2.3M 2.7M 1.53M 1.75M 2.17M